GB:SAR Stock Latest News
Company AnnouncementsSareum enters AIM Capital Access Window to fund advance of lead autoimmune drug3w ago
Company AnnouncementsSareum Boosts Capital as Warrants Add to AIM-Listed Share Base2M ago
Company AnnouncementsSareum boosts equity base as warrant holders subscribe for new AIM shares2M ago
Company AnnouncementsSareum Raises Capital Through Warrant Exercise as Share Base Expands2M ago
Company AnnouncementsSareum Completes Key Toxicology Milestone for Autoimmune Drug Candidate SDC-18013M ago
Company AnnouncementsSareum’s SDC-1801 Phase 1 Data Published, Paving Way for Phase 2-Ready Package4M agoCompany AnnouncementsSareum Restarts Key Toxicology Study as TYK2 Pipeline and Partnering Drive Half-Year Progress7M ago
Company AnnouncementsSareum to Release Interim Results and Host Live Investor Presentation8M ago
Company AnnouncementsSareum Restarts Phase 2-Enabling Toxicology Programme for Lead Autoimmune Drug SDC-18018M ago
Company AnnouncementsSareum Holdings Passes All Resolutions at AGM, Strengthening Governance10M ago
Company AnnouncementsSareum Holdings Advances Pipeline and Strengthens Portfolio10M ago
Company AnnouncementsSareum Holdings Announces AGM and Releases Annual Report11M agoCompany AnnouncementsSareum Holdings Enhances Financial Advisory Team with New Joint Broker Appointment1y ago
Company AnnouncementsSareum Holdings Reports Progress in Drug Development and Strategic Collaborations1y ago
- Company AnnouncementsSareum Holdings Discontinues Toxicology Study for SDC-1801 Amid Safety Concerns1y ago
- Company AnnouncementsSareum Holdings to Announce Financial Results and Host Investor Presentation1y ago
- Company AnnouncementsSareum Holdings Raises Funds Through Warrant Exercise1y ago
- Company AnnouncementsSareum Holdings Increases Share Capital Through Warrant Exercise1y ago
Company AnnouncementsSareum Holdings Expands Share Capital Through Warrant Exercise1y agoCompany AnnouncementsSareum Holdings Partners with Receptor.AI to Advance Neuroinflammatory Drug Discovery1y ago
